In the present study, we observed that patients with CAS had significantly elevated serum levels of CX3CL1, CXCL12, CCL19, CCL21, CCL2, and CCL5 compared to control individuals, suggesting that these chemokines are intricately involved in the initiation and progression of atherosclerosis. The gene discussed is CCL19; the disease is atherosclerosis.